Funds · IMRX

Who owns IMRX?

Institutional ownership of Immuneering Corporation from Form 13F, Q2 2026

112 institutional managers reported holding Immuneering Corporation (IMRX) in Form 13F filings for Q2 2026, with 34,451,908 shares worth $172M. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 5,146,225 shares (+17.6%). 38 opened new positions and 21 sold out.

Funds holding
112
Value held
$172M
New / sold out
38 / 21
Net shares, same filers
+17.6%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of IMRX

FundValueShare of 13F holdingsSharesMove
FMR LLC$48.4M28.2%9,704,610Unchanged
BlackRock, Inc.$21.8M12.7%4,374,020Added
Sanofi$13.5M7.9%2,708,559Unchanged
Vanguard Capital Management LLC$11.4M6.6%2,286,434Unchanged
Price T Rowe Associates Inc$9.7M5.6%1,936,076Added
Geode Capital Management, LLC$6.8M4.0%1,370,750Added
State Street Corp$5.0M2.9%1,001,995Added
DCF Advisers, LLC$3.9M2.3%790,000Added
Marshall Wace, LLP$3.7M2.1%731,897Trimmed
Connor, Clark & Lunn Investment Management Ltd.$3.0M1.7%601,255Added
Alethea Capital Management, LLC$2.4M1.4%472,935Added
Summit Financial, LLC$2.3M1.3%452,264Added
UBS Group AG$2.2M1.3%448,857Added
Nuveen, LLC$2.2M1.3%438,362New
Northern Trust Corp$2.2M1.3%436,992Added
Levin Capital Strategies, L.p.$2.1M1.2%414,000Added
Citadel Advisors LLC$1.9M1.1%386,411Trimmed
Vanguard Fiduciary Trust Co$1.8M1.0%360,764Added
Vanguard Portfolio Management LLC$1.8M1.0%359,085New
Gsa Capital Partners LLP$1.7M1.0%343,303Added
Millennium Management LLC$1.6M1.0%330,402Trimmed
Burkehill Global Management, LP$1.5M0.9%300,000Unchanged
Two Sigma Investments, LP$1.4M0.8%288,420Added
Morgan Stanley$1.1M0.7%226,491Trimmed
Occam Crest Management LP$1.1M0.8%278,498Trimmed

Share of 13F holdings is each fund's shares as a share of the 34,451,908 IMRX shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. BlackRock, Inc. Added+$14.3M
  2. State Street Corp Added+$3.7M
  3. Geode Capital Management, LLC Added+$3.7M
  4. DCF Advisers, LLC Added+$3.2M
  5. Alethea Capital Management, LLC Added+$2.2M
  6. Nuveen, LLC New+$2.2M
  7. Levin Capital Strategies, L.p. Added+$2.0M
  8. Vanguard Portfolio Management LLC New+$1.8M
  9. Northern Trust Corp Added+$1.6M
  10. Gsa Capital Partners LLP Added+$1.3M

Biggest sellers in Q2 2026

  1. Marshall Wace, LLP Trimmed-$6.3M
  2. Millennium Management LLC Trimmed-$3.9M
  3. Goldman Sachs Group Inc Trimmed-$1.2M
  4. Occam Crest Management LP Trimmed-$1.1M
  5. Diametric Capital, LP Sold out-$922K
  6. Squarepoint Ops LLC Trimmed-$840K
  7. Wellington Management Group LLP Sold out-$824K
  8. 683 Capital Management, LLC Sold out-$794K
  9. Barclays PLC Trimmed-$507K
  10. Hudson Bay Capital Management LP Sold out-$505K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $47.4M and sold $21.8M; 34 added and 19 trimmed.

Schedule 13D and 13G filings on IMRX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about IMRX ownership

Who owns IMRX stock?
112 institutional investment managers reported IMRX positions in their Form 13F filings for Q2 2026, holding 34,451,908 shares worth $172M in total. FMR LLC reported the largest position.
Are funds buying or selling IMRX?
In Q2 2026, 38 managers opened new IMRX positions, 34 added, 19 trimmed and 21 sold out. Managers that filed in both quarters added a net 5,146,225 shares.
How current is this IMRX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IMRX by CUSIP. Options are left out. IMRX news and filings · IMRX insider trades · Top funds